Showing results (161-170 of 222) with videos related to

Sort By:
Pageof 23
JCO Oncology Practice|December 5, 2019
Impact of Addition of Carboplatin AUC ≥ 4 to Antiemetic Guidelines for Triple Antiemetic Prophylaxis: A Gap in Quality of Care, Guideline Adoption, and Avoiding Acute CareRudolph M Navari, Kathryn J Ruddy, Thomas W LeBlanc, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 4, 2024
Recalling what we thought we knew about recall periods: a qualitative descriptive study of how adults diagnosed with cancer use recall periods for patient-reported outcome items about physical functionTheresa Coles, Kate Plyler, Alexy Hernandez, et al.
Blood Advances|May 10, 2022
Code status transitions in patients with high-risk acute myeloid leukemiaHannah R Abrams, Ryan D Nipp, Lara Traeger, et al.
Behavioral Sleep Medicine|April 10, 2024
Mindful Night-to-Day: A Pilot Feasibility Trial of a Mindfulness-Based Insomnia and Symptom Management Intervention for Patients with Hematologic CancerHannah M Fisher, Kelly A Hyland, Shannon N Miller, et al.
Transplantation and Cellular Therapy|June 12, 2025
Prolonged hospitalization for hematopoietic cell transplantation (HCT): Characteristics, risk factors and associations with patient-reported and clinical outcomesLucy Gao, Ashley Nelson, Anna Barata, et al.
Patient Preference and Adherence|October 24, 2024
Patient, Care Partner, and Physician Voices in Treatment Decision-Making for Multiple MyelomaLisa Dwyer Orr, Dee Lin, Bingcao Wu, et al.
Contemporary Clinical Trials|January 27, 2024
Protocol for multi-site randomized trial of inpatient palliative care for patients with hematologic malignancies undergoing hematopoietic stem cell transplantationDaniel Yang, Richard Newcomb, Alison R Kavanaugh, et al.
Acta Haematologica|May 7, 2026
Treatment Decision-making for Individuals with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in the United StatesCatherine C Coombs, Thomas W LeBlanc, Katherine B Winfree, et al.
The Oncologist|December 17, 2022
Duration of Chemotherapy-Induced Nausea and Vomiting (CINV) as a Predictor of Recurrent CINV in Later CyclesRudolph Navari, Gary Binder, Alex Molasiotis, et al.
Future Oncology (London, England)|February 28, 2024
Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myelomaLuciano J Costa, Thomas W LeBlanc, Hans Tesch, et al.
Pageof 23